Long-Term Immunogenicity of Measles Vaccine After Coadministration with Live Attenuated Japanese Encephalitis Vaccine

This follow-up study to PATH's original coadministration trial demonstrated that measles seroprotection rates were still high one year post-vaccination among infants who originally seroconverted for measles.

Author(s): PATH

Published: 2007